knowledge -WSS

knowledge

author：explore 2025-09-29 19:28:39 - browse：9

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Bristol 'take

WSS

What to expect at HLTH 2023, the health care industry conference

FDA authorizes Novavax’s updated Covid

Dana Farber says 6 studies to be retracted and 31 corrected

TikTok, Instagram influencers need more rules for drug ads

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Why Charlie Gard's case is so disturbing to Americans

focus

knowledge

entertainment

Moonlake's readout produced a cash windfall. Risks remain

Immunocompromised patients offer clues on chronic Covid

Trump demands the U.S. pay no more for drugs than other countries … again

When women are denied an abortion, their children fare worse than peers

Supreme Court strikes down use of affirmative action

Head of FDA's diagnostics center, who led through Covid, retires

The high cost of giving birth even with insurance

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Bright Health sells Medicare Advantage business to Molina

Phenylephrine and the overlooked value of the placebo effect

focus

A Q&A with the global head of Boehringer Ingelheim's innovation unit

FDA panel signals lack of confidence in Amgen cancer drug data

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Immunocompromised patients offer clues on chronic Covid

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Pumping milk in bathrooms at health conferences is common

hotspot

focus

focus

Wikipedia